Books > Earth & environment > The environment > Pollution & threats to the environment
|
Buy Now
Guidance on PFAS Exposure, Testing, and Clinical Follow-Up (Paperback)
Loot Price: R1,230
Discovery Miles 12 300
|
|
Guidance on PFAS Exposure, Testing, and Clinical Follow-Up (Paperback)
Expected to ship within 12 - 17 working days
|
In thousands of communities across the United States, drinking
water is contaminated with chemicals known as perfluoroalkyl and
polyfluoroalkyl substances (PFAS). PFAS are used in a wide range of
products, such as non-stick cookware, water and stain repellent
fabrics, and fire-fighting foam, because they have properties that
repel oil and water, reduce friction, and resist temperature
changes. PFAS can leak into the environment where they are made,
used, disposed of, or spilled. PFAS exposure has been linked to a
number of adverse health effects including certain cancers, thyroid
dysfunction, changes in cholesterol, and small reductions in birth
weight. This report recommends that the Centers for Disease Control
and Prevention (CDC) update its clinical guidance to advise
clinicians to offer PFAS blood testing to patients who are likely
to have a history of elevated exposure, such as those with
occupational exposures or those who live in areas known to be
contaminated. If testing reveals PFAS levels associated with an
increased risk of adverse effects, patients should receive regular
screenings and monitoring for these and other health impacts.
Guidance on PFAS Exposure, Testing, and Clinical Follow-Up
recommends that the CDC, Agency for Toxic Substances and Disease
Registry (ATSDR), and public health departments support clinicians
by creating educational materials on PFAS exposure, potential
health effects, the limitations of testing, and the benefits and
harms of testing. Table of Contents Front Matter Summary 1
Introduction 2 Principles for Decision Making Under Uncertainty 3
Potential Health Effects of PFAS 4 PFAS Exposure Reduction 5 PFAS
Testing and Concentrations to Inform Clinical Care of Exposed
Patients 6 Guidance for Clinicians on Exposure Determination, PFAS
Testing, and Clinical Follow-Up 7 Revising ATSDR's PFAS Clinical
Guidance 8 Implementing the Committee's Recommendations to Improve
Public Health Appendix A: Committee Member, Staff, and Community
Liaison Biographies Appendix B: Summary of the Committee's Town
Halls Appendix C: Public Meeting Agendas Appendix D: Evidence
Review: Methods and Approach Appendix E: White Paper: Review of the
PFAS Personal Intervention Literature
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.